NeuroOne Medical Technologies Corporation Common Stock vs. ResMed Inc.
NMTC
NeuroOne Medical Technologies Corporation Common Stock
$1.33 +0.00%
VS RMDResMed Inc.
$222.00 +0.05%
ResMed Inc. (RMD) comes out ahead, leading on 5 of 8 compared factors.
Size & Scale
| NMTC | RMD | |
|---|---|---|
| Market Cap | $12.11 million | $32.02 billion |
| Revenue (TTM) | $9.47 million | $5.65 billion |
| Net Income (TTM) | $-7,445,464 | $1.52 billion |
RMD leads on 3 of 3 size & scale factors.
Valuation
| NMTC | RMD | |
|---|---|---|
| P/E Ratio | — | 21.28 |
| Price / Book | 3.21 | 4.86 |
| Price / Sales | 1.28 | 5.66 |
NMTC leads on 2 of 2 valuation factors.
Profitability
| NMTC | RMD | |
|---|---|---|
| Net Margin | -78.63% | 26.94% |
| Return on Equity | -197.62% | 23.13% |
RMD leads on 2 of 2 profitability factors.
Dividend
| NMTC | RMD | |
|---|---|---|
| Dividend Yield | — | 1.19% |
| Payout Ratio | — | 25.31 |
NMTC and RMD split the dividend factors evenly.
Risk & Sentiment
| NMTC | RMD | |
|---|---|---|
| Short Interest | 0.00% | 4.04% |
NMTC leads on 1 of 1 risk & sentiment factors.
Dig deeper: NMTC overview, NMTC financials, RMD overview, RMD financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.